Can Ozempic Fix Our Obesity Crisis?

View the Show Notes For This Episode Get Free Weekly Health Tips
from Dr. Hyman Sign Up for Dr. Hyman’s Weekly Longevity Journal Get
Ad-free Episodes & Dr. Hyman+ Audio Exclusives Ozempic and
other GLP-1 agonists like Wegovy have exploded as “miracle weight
loss drugs.” But as the research unfolds, we’re quickly discovering
that these drugs are not risk free and come with some very
concerning side effects. In today’s episode of my series I’m
calling Health Bites, I dive deep into the complexities of Ozempic.
From nationwide shortages, high costs, the lack of insurance
coverage, and severe, somewhat common, side effects, I explore the
hurdles of Ozempic and question if it's truly a sustainable
solution to our growing obesity crisis.  This episode is
brought to you by Mitopure and Cozy Earth. Support essential
mitochondrial health and save 10% on Mitopure. Visit
TimelineNutrition.com/Drhyman and use code DRHYMAN10. Right now,
you can save 40% when you upgrade to Cozy Earth sheets. Just head
over to CozyEarth.com and use code DRHYMAN. Here are more details
from the episode (audio version / Apple Subscriber version):
Current and potential uses for Ozempic and GLP-1 (6:42 / 4:01)
Common side effects from Ozempic (8:48 / 6:07) Understanding the
obesity and chronic disease crisis (9:33 / 6:52) Long-term risks
associated with Ozempic (14:47 / 12:06) Combatting the idea that
obesity is genetic (17:54 / 15:13) Can you be healthy at any size?
(20:37 / 17:55) How traditional medicine misses the mark in
addressing obesity (24:36 / 21:55) Clinical research findings of
Ozempic use (31:44 / 29:03) Addressing the root cause of obesity
and type 2 diabetes (35:34 / 32:53) Mentioned in this episode Dr.
Hyman’s Free Sleep Masterclass Function Health The 10-day Detox
Diet Connect with Dr. Mark Hyman on Twitter, Instagram, Facebook,
and YouTube